Nucleosomes Modulate DNA Interstrand Crosslink Repair

核小体调节 DNA 链间交联修复

基本信息

项目摘要

DESCRIPTION (provided by applicant): Chromatin structure plays a critical role in modulation of cellular response to DNA damage. The mechanism utilized by repair proteins to locate target sites on damaged nucleosomal DNA is critical to understanding these repair processes. The present proposal will examine the effect of nucleosome structure on the ability of human repair proteins to interact with and incise DNA containing interstrand cross-links, produced by potentially mutagenic and carcinogenic environmental agents such as psoralen plus UVA light, and to ascertain whether there is a relationship between the processive mechanism of action shown by the endonucleases involved in this process and their ability to incise damaged nucleosomal DNA. We have isolated a protein complex from the nuclei of normal human cells that contains all the proteins needed for recognition and incision of DNA containing interstrand cross-links. In cells from patients with the cancer-prone, repair deficient genetic disease, xeroderma pigmentosum, complementation group A (XPA), this same complex has normal levels of activity on cross-linked naked DNA but is defective in ability to incise damaged nucleosomal DNA. This defect correlates with the distributive mechanism of action utilized by the endonucleases present in the XPA complex, in contrast to the processive mechanism of action of the normal endo-nucleases, and is related to the loss of ability of the XPA protein to act as a processivity factor. The present proposal will focus on this new role of XPA as a processivity factor and on which domain in XPA is responsible for its mechanism of action. Site-directed mutagenesis will be used to create selected mutations in XPA. Recombinant mutant proteins will be produced and examined to ascertain which domain(s) is needed for its action as a processivity factor on damaged naked DNA and the importance of this domain for its action on damaged nucleosomal DNA. DNA substrates will be constructed that contain a positioned nucleosome and a site-specific 4,5',8-trimethyl-psoralen (TMP) interstrand cross-link in either the core or linker region. This will allow evaluation of the effect of nucleosome structure and cross-link location on the influence of the mutant and wild type XPA proteins on incisions produced by the normal and XPA complexes on damaged DNA. Whether defects in ability of the XPA complex to incise damaged nucleosomal DNA can be corrected by the wild type or mutant XPA proteins will also be examined. These studies will provide important insights into the complex mechanism by which interstrand cross-links are repaired in nucleosomal DNA, the importance of a processive mechanism of action by repair proteins on damaged nucleosomal DNA, and the severe consequences that occur in individuals when this mechanism is defective.
描述(由申请人提供):染色质结构在调节细胞对DNA损伤的反应中起关键作用。修复蛋白在受损核小体DNA上定位靶位点的机制对于理解这些修复过程至关重要。本提案将研究核小体结构对人类修复蛋白与含有链间交联的DNA相互作用和切割DNA的能力的影响,所述链间交联由潜在的致突变和致癌环境因子如peptide + UVA光产生,并确定参与该过程的核酸内切酶所显示的进行性作用机制与它们切割受损细胞的能力之间是否存在关系,核小体DNA我们已经从正常人类细胞的细胞核中分离出一种蛋白质复合物,它含有识别和切割含有链间交联的DNA所需的所有蛋白质。在来自具有癌症倾向的、修复缺陷型遗传疾病、着色性干皮病、互补组A(XPA)的患者的细胞中,这种相同的复合物对交联的裸DNA具有正常水平的活性,但在切割受损的核小体DNA的能力上是有缺陷的。这种缺陷与XPA复合物中存在的核酸内切酶所利用的作用的分布机制相关,与正常核酸内切酶的进行性作用机制相反,并且与XPA蛋白作为持续合成因子的能力丧失有关。目前的建议将集中在XPA作为合成因子的新作用,以及XPA中的哪个域负责其作用机制。定点诱变将用于在XPA中产生选定的突变。重组突变蛋白将被生产和检查,以确定其作为受损裸DNA的持续合成因子的作用需要哪个结构域,以及该结构域对于其对受损核小体DNA的作用的重要性。将构建DNA底物,其含有定位的核小体和在核心或接头区中的位点特异性4,5 ',8-三甲基-戊二烯(TMP)链间交联。这将允许评估核小体结构和交联位置对突变型和野生型XPA蛋白对由正常和XPA复合物在受损DNA上产生的切口的影响的影响。还将检查XPA复合物切割受损核小体DNA的能力缺陷是否可以通过野生型或突变型XPA蛋白来校正。这些研究将提供重要的见解复杂的机制,其中链间交联修复在核小体DNA,修复蛋白对受损的核小体DNA的重要性,以及严重的后果,发生在个人时,这种机制是有缺陷的进行性机制的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Muriel W Lambert其他文献

Muriel W Lambert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Muriel W Lambert', 18)}}的其他基金

Nucleosomes Modulate DNA Interstrand Crosslink Repair
核小体调节 DNA 链间交联修复
  • 批准号:
    6897028
  • 财政年份:
    2003
  • 资助金额:
    $ 29.55万
  • 项目类别:
Nucleosomes Modulate DNA Interstrand Crosslink Repair
核小体调节 DNA 链间交联修复
  • 批准号:
    6790513
  • 财政年份:
    2003
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    2445310
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    6389513
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA Repair Defect in Fanconi Anemia, Group A
范可尼贫血 A 组的 DNA 修复缺陷
  • 批准号:
    6987836
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    2233343
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    2604115
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    2735270
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA Repair Defect in Fanconi Anemia, Group A
范可尼贫血 A 组的 DNA 修复缺陷
  • 批准号:
    7154148
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
范可尼贫血 A 组中的 DNA 修复缺陷
  • 批准号:
    2233342
  • 财政年份:
    1995
  • 资助金额:
    $ 29.55万
  • 项目类别:

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 29.55万
  • 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
  • 批准号:
    2338236
  • 财政年份:
    2024
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
DNA Repair State Machines
DNA 修复状态机
  • 批准号:
    EP/X027406/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Research Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
  • 批准号:
    2246561
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
  • 批准号:
    10734425
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了